--- title: "Zhejiang Nhu Company Ltd. (002001.SZ)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/002001.SZ.md" symbol: "002001.SZ" name: "Zhejiang Nhu Company Ltd." industry: "Specialty Chemicals" datetime: "2026-03-03T09:51:00.641Z" locales: - [en](https://longbridge.com/en/quote/002001.SZ.md) - [zh-CN](https://longbridge.com/zh-CN/quote/002001.SZ.md) - [zh-HK](https://longbridge.com/zh-HK/quote/002001.SZ.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002001.SZ.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002001.SZ.md) # Zhejiang Nhu Company Ltd. (002001.SZ) ## Company Overview Zhejiang NHU Company Ltd. engages in the production and sale of nutrition, flavor and fragrance, and new polymer materials in the People’s Republic of China. The company offers nutrition products, such as vitamin E, vitamin H, vitamin A, vitamin C, methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, vitamin B5, vitamin B6, vitamin B12, serine, cystine, tryptophan, etc. for use in feed additives, and nutrition supplements of food, beverages, health food, etc.; and flavor and fragrance products comprising linalool, citral, citronellyl nitrile, methyl heptanone, pyranol, hydroxy citronellal, linalool, tetrahydrolinalool, methyl dihydrojasmonate, citronellol, geraniol 60, geraniol 98, citronellal, nerol, citronellyl acetate, geranyl acetate 60, geranyl acetate 98, neryl acetate, tetrahydrogeraniol, methylionone, a-ionone, ß-ionone, isomethyl ionone, linalyl acetate, ethyl linalool, L-menthol, and DL-methanol, cis-3-hexenyl acetate, cis-3-hexenyl salicylate, ligustral, and cis-3-hexenol for use in the personal care, cosmetic, and food fields. | Item | Detail | |------|--------| | Industry | Specialty Chemicals | | Exchange | CN Market | | Website | [www.cnhu.com](https://www.cnhu.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: B > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-03-03T04:30:10.000Z **Overall: B (0.31)** **Industry**: Specialty Chemicals | Metric | Value | |--------|-------| | Industry Ranking | 1 / 154 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock. **Multi Score**: B #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 12.99% | | | Net Profit YoY | 56.77% | | | P/B Ratio | 3.10 | | | Dividend Ratio | 2.15% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 100248876335.45 | | | Revenue | 22551539560.10 | | #### Multi Score Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 24.14% | A | | Profit Margin | 32.04% | A | | Gross Margin | 45.46% | B | | Revenue YoY | 12.99% | B | | Net Profit YoY | 56.77% | B | | Total Assets YoY | 8.58% | B | | Net Assets YoY | 17.27% | A | | Cash Flow Margin | 312.09% | C | | OCF YoY | 12.99% | B | | Turnover | 0.52 | C | | Gearing Ratio | 28.25% | B | ```chart-data:radar { "title": "Longbridge Financial Score - Zhejiang Nhu Company Ltd.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "12.99%", "rating": "" }, { "name": "Net Profit YoY", "value": "56.77%", "rating": "" }, { "name": "P/B Ratio", "value": "3.10", "rating": "" }, { "name": "Dividend Ratio", "value": "2.15%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "100248876335.45", "rating": "" }, { "name": "Revenue", "value": "22551539560.10", "rating": "" } ] }, { "name": "Multi Score", "grade": "B", "indicators": [ { "name": "ROE", "value": "24.14%", "rating": "A" }, { "name": "Profit Margin", "value": "32.04%", "rating": "A" }, { "name": "Gross Margin", "value": "45.46%", "rating": "B" }, { "name": "Revenue YoY", "value": "12.99%", "rating": "B" }, { "name": "Net Profit YoY", "value": "56.77%", "rating": "B" }, { "name": "Total Assets YoY", "value": "8.58%", "rating": "B" }, { "name": "Net Assets YoY", "value": "17.27%", "rating": "A" }, { "name": "Cash Flow Margin", "value": "312.09%", "rating": "C" }, { "name": "OCF YoY", "value": "12.99%", "rating": "B" }, { "name": "Turnover", "value": "0.52", "rating": "C" }, { "name": "Gearing Ratio", "value": "28.25%", "rating": "B" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 13.87 | 3/154 | 11.88 | 10.35 | 9.88 | | PB | 3.10 | 73/154 | 2.48 | 2.36 | 2.23 | | PS (TTM) | 4.45 | 81/154 | 3.44 | 3.27 | 3.03 | | Dividend Yield | 2.15% | 11/154 | 3.58% | 3.11% | 2.89% | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | NHU (002001.SZ) | A | B | C | B | C | B | | 02 | HCSC (600378.SH) | B | A | B | B | B | B | | 03 | DING LONG (300054.SZ) | B | B | C | C | B | B | | 04 | CAPCHEM (300037.SZ) | B | B | E | A | B | B | | 05 | Cathay Biotech (688065.SH) | C | A | D | A | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-25T16:00:00.000Z Total Analysts: **9** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 4 | 44% | | Overweight | 1 | 11% | | Hold | 3 | 33% | | Sell | 1 | 11% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 33.89 | | Highest Target | 38.24 | | Lowest Target | 16.80 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002001.SZ/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002001.SZ/norm.md) - [Related News](https://longbridge.com/en/quote/002001.SZ/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002001.SZ/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**